Safety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer

被引：0
|
作者：
Kotani, D. [1 ]
Kuboki, Y. [1 ]
Yasuda, K. [1 ]
Nakamura, Y. [1 ]
Kawazoe, A. [1 ]
Bando, H. [1 ]
Taniguchi, H. [1 ]
Shitara, K. [1 ]
Yoshino, T. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106P
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Kotani, Daisuke
    Kuboki, Yasutoshi
    Horasawa, Satoshi
    Kaneko, Asumi
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Bando, Hideaki
    Taniguchi, Hiroya
    Shitara, Kohei
    Kojima, Takashi
    Tsuji, Akihito
    Yoshino, Takayuki
    [J]. BMC CANCER, 2019, 19 (01)
  • [2] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Daisuke Kotani
    Yasutoshi Kuboki
    Satoshi Horasawa
    Asumi Kaneko
    Yoshiaki Nakamura
    Akihito Kawazoe
    Hideaki Bando
    Hiroya Taniguchi
    Kohei Shitara
    Takashi Kojima
    Akihito Tsuji
    Takayuki Yoshino
    [J]. BMC Cancer, 19
  • [3] Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status
    C. Carriles
    P. Jimenez-Fonseca
    M. Sánchez-Cánovas
    P. Pimentel
    A. Carmona-Bayonas
    T. García
    M. Carbajales-Álvarez
    A. Lozano-Blázquez
    [J]. Clinical and Translational Oncology, 2019, 21 : 1781 - 1785
  • [4] Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status
    Carriles, C.
    Jimenez-Fonseca, P.
    Sanchez-Canovas, M.
    Pimentel, P.
    Carmona-Bayonas, A.
    Garcia, T.
    Carbajales-Alvarez, M.
    Lozano-Blazquez, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (12): : 1781 - 1785
  • [5] Bevacizumab improves efficacy of trifluridine/tipiracil (TAS-102) in patients with chemorefractory metastatic colorectal cancer: a Danish randomized trial
    Pfeiffer, P.
    Yilmaz, M.
    Moller, S.
    Zitnjak, D.
    Maltha, L.
    Krogh, M.
    Winther, S.
    Petersen, L.
    Hejlersen, F.
    Thomsen, K.
    Qvortrup, C.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [6] Neutropenia as a predictor of efficacy in the treatment of metastatic colorectal cancer with TAS-102 (trifluridine - tipiracil).
    Rodriguez Garces, Maria Yeray
    Senin, Loreto Dominguez
    Urbano, Maria Amor
    Tarazona, Victoria Avino
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15564 - E15564
  • [7] Safety for trifluridine/tipiracil (TAS-102) with bevacizumab combination in patients with refractory metastatic colorectal cancer in real-world clinical practice: The single-institutional experience.
    Yasuda, Kayo
    Kotani, Daisuke
    Kuboki, Yasutoshi
    Fukuoka, Shota
    Bando, Hideaki
    Kawazoe, Akihito
    Nakamura, Yoshiaki
    Shitara, Kohei
    Yoshino, Takayuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Fengxiang Huang
    Haiyan Yang
    Wenguang Bao
    Yehong Bin
    Shengsheng Zhou
    Man Wang
    Xiaoping Lv
    [J]. Clinical and Translational Oncology, 2024, 26 : 468 - 476
  • [9] Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Huang, Fengxiang
    Yang, Haiyan
    Bao, Wenguang
    Bin, Yehong
    Zhou, Shengsheng
    Wang, Man
    Lv, Xiaoping
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (02): : 468 - 476
  • [10] Efficacy, tolerability, and manageability of TAS-102 plus bevacizumab for metastatic colorectal cancer patients in clinical practice.
    Ishikawa, Hideki
    Suzuki, Koichi
    Kakizawa, Nao
    Watanabe, Fumiaki
    Ichida, Kosuke
    Takayama, Yuji
    Fukui, Taro
    Hasegawa, Fumi
    Kikugawa, Rina
    Futsuhara, Kazushige
    Tsujinaka, Shingo
    Miyakura, Yasuyuki
    Noda, Hiroshi
    Rikiyama, Toshiki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345